FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022222077> ?p ?o ?g. }

• W2022222077 endingPage "783" @default.
• W2022222077 startingPage "773" @default.
• W2022222077 abstract "Several potential molecular-targeted anticancer drugs focus on the inhibition of receptor tyrosine kinase and tumour growth, but these tyrosine kinase inhibitors (TKI) have been reported that the mutations of kinase-related signal molecule genes in cancer cells lead to the drug resistance. To overcome this issue, we have designed a novel targeting anticancer 'hybrid-peptide' EGFR-lytic peptide, in which epidermal growth factor receptor (EGFR) binding peptide is conjugated with a newly designed lytic-type peptide containing cationic-rich amino acids that disintegrates the cell membrane to kill cancer cells. In this report, cytotoxic activity of EGFR-lytic peptide was investigated in various human cancer and normal cell lines. It was found that the resulting conformational change in the novel lytic peptide enabled it to bind selectively to the membrane of cancer cells, and due to its acquired synergistic action, hybrid peptide demonstrated selective destruction of cancer cells as swiftly as 10 min after exposure. Treatment with EGFR-lytic peptide exerted a sufficient in vitro cytotoxic activity against TKI-resistant cancer cells with K-ras mutations. Moreover, in vivo analyses revealed that this peptide displayed significant antitumour activity in mouse xenograft models of both human K-ras mutation negative and positive cancers. Thus, hybrid peptide can be a unique and powerful tool for a new cancer-targeted therapy." @default.
• W2022222077 created "2016-06-24" @default.
• W2022222077 creator A5012808950 @default.
• W2022222077 creator A5022157564 @default.
• W2022222077 creator A5022441524 @default.
• W2022222077 creator A5031321538 @default.
• W2022222077 creator A5032922270 @default.
• W2022222077 creator A5037731704 @default.
• W2022222077 creator A5048566624 @default.
• W2022222077 creator A5083344330 @default.
• W2022222077 date "2011-03-01" @default.
• W2022222077 modified "2023-10-15" @default.
• W2022222077 title "A novel hybrid peptide targeting EGFR-expressing cancers" @default.
• W2022222077 cites W1557061959 @default.
• W2022222077 cites W1587050401 @default.
• W2022222077 cites W1974024530 @default.
• W2022222077 cites W1986053719 @default.
• W2022222077 cites W1998056948 @default.
• W2022222077 cites W2002972290 @default.
• W2022222077 cites W2010174111 @default.
• W2022222077 cites W2014271697 @default.
• W2022222077 cites W2019915688 @default.
• W2022222077 cites W2057916782 @default.
• W2022222077 cites W2059780149 @default.
• W2022222077 cites W2060483617 @default.
• W2022222077 cites W2062348697 @default.
• W2022222077 cites W2064047613 @default.
• W2022222077 cites W2068863414 @default.
• W2022222077 cites W2070693578 @default.
• W2022222077 cites W2073334034 @default.
• W2022222077 cites W2081477031 @default.
• W2022222077 cites W2082063496 @default.
• W2022222077 cites W2095615236 @default.
• W2022222077 cites W2095838056 @default.
• W2022222077 cites W2096088010 @default.
• W2022222077 cites W2101322634 @default.
• W2022222077 cites W2117660120 @default.
• W2022222077 cites W2121831273 @default.
• W2022222077 cites W2130031552 @default.
• W2022222077 cites W2155311724 @default.
• W2022222077 cites W4243226078 @default.
• W2022222077 doi "https://doi.org/10.1016/j.ejca.2010.10.021" @default.
• W2022222077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21112771" @default.
• W2022222077 hasPublicationYear "2011" @default.
• W2022222077 type Work @default.
• W2022222077 sameAs 2022222077 @default.
• W2022222077 citedByCount "63" @default.
• W2022222077 countsByYear W20222220772012 @default.
• W2022222077 countsByYear W20222220772013 @default.
• W2022222077 countsByYear W20222220772014 @default.
• W2022222077 countsByYear W20222220772015 @default.
• W2022222077 countsByYear W20222220772016 @default.
• W2022222077 countsByYear W20222220772017 @default.
• W2022222077 countsByYear W20222220772018 @default.
• W2022222077 countsByYear W20222220772019 @default.
• W2022222077 countsByYear W20222220772020 @default.
• W2022222077 countsByYear W20222220772021 @default.
• W2022222077 countsByYear W20222220772022 @default.
• W2022222077 countsByYear W20222220772023 @default.
• W2022222077 crossrefType "journal-article" @default.
• W2022222077 hasAuthorship W2022222077A5012808950 @default.
• W2022222077 hasAuthorship W2022222077A5022157564 @default.
• W2022222077 hasAuthorship W2022222077A5022441524 @default.
• W2022222077 hasAuthorship W2022222077A5031321538 @default.
• W2022222077 hasAuthorship W2022222077A5032922270 @default.
• W2022222077 hasAuthorship W2022222077A5037731704 @default.
• W2022222077 hasAuthorship W2022222077A5048566624 @default.
• W2022222077 hasAuthorship W2022222077A5083344330 @default.
• W2022222077 hasConcept C121608353 @default.
• W2022222077 hasConcept C154317977 @default.
• W2022222077 hasConcept C170493617 @default.
• W2022222077 hasConcept C182615771 @default.
• W2022222077 hasConcept C185592680 @default.
• W2022222077 hasConcept C202751555 @default.
• W2022222077 hasConcept C203014093 @default.
• W2022222077 hasConcept C2522874641 @default.
• W2022222077 hasConcept C2779281246 @default.
• W2022222077 hasConcept C2779438470 @default.
• W2022222077 hasConcept C42362537 @default.
• W2022222077 hasConcept C502942594 @default.
• W2022222077 hasConcept C54355233 @default.
• W2022222077 hasConcept C55493867 @default.
• W2022222077 hasConcept C86803240 @default.
• W2022222077 hasConcept C96232424 @default.
• W2022222077 hasConceptScore W2022222077C121608353 @default.
• W2022222077 hasConceptScore W2022222077C154317977 @default.
• W2022222077 hasConceptScore W2022222077C170493617 @default.
• W2022222077 hasConceptScore W2022222077C182615771 @default.
• W2022222077 hasConceptScore W2022222077C185592680 @default.
• W2022222077 hasConceptScore W2022222077C202751555 @default.
• W2022222077 hasConceptScore W2022222077C203014093 @default.
• W2022222077 hasConceptScore W2022222077C2522874641 @default.
• W2022222077 hasConceptScore W2022222077C2779281246 @default.
• W2022222077 hasConceptScore W2022222077C2779438470 @default.
• W2022222077 hasConceptScore W2022222077C42362537 @default.
• W2022222077 hasConceptScore W2022222077C502942594 @default.
• W2022222077 hasConceptScore W2022222077C54355233 @default.
• W2022222077 hasConceptScore W2022222077C55493867 @default.

• next